| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |